Cart
sales@molnova.com
3-Hydroxyoctanoic Acid
CAS No. 14292-27-4
3-Hydroxyoctanoic Acid( —— )
Catalog No. M28858 CAS No. 14292-27-4
3-Hydroxyoctanoic Acid is one of the hydroxy-carboxylic acids (HCAs) that serve as intermediates of energy metabolism. It is an agonist of the orphan receptor GPR109B.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 80 | In Stock |
|
| 25MG | 123 | In Stock |
|
| 50MG | 177 | In Stock |
|
| 100MG | 268 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3-Hydroxyoctanoic Acid
-
NoteResearch use only, not for human use.
-
Brief Description3-Hydroxyoctanoic Acid is one of the hydroxy-carboxylic acids (HCAs) that serve as intermediates of energy metabolism. It is an agonist of the orphan receptor GPR109B.
-
Description3-Hydroxyoctanoic Acid is one of the hydroxy-carboxylic acids (HCAs) that serve as intermediates of energy metabolism. It is an agonist of the orphan receptor GPR109B.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetGPR
-
RecptorD3 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number14292-27-4
-
Formula Weight160.21
-
Molecular FormulaC8H16O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 42.5 mg/mL (265.28 mM)
-
SMILESCCCCCC(CC(O)=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rudmann DG, et al. Epididymal and systemic phospholipidosis in rats and dogs treated with the dopamine D3 selective antagonist PNU-177864. Toxicol Pathol. 2004 May-Jun;32(3):326-32.
molnova catalog
related products
-
Azathioprine
Azathioprine is an immunosuppressive drug, inhibiting purine synthesis and GTP-binding protein Rac1 activation, used in the treatment of organ transplantation and autoimmune diseases.
-
Bimatoprost acid
Bimatoprost acid is a metabolically stable analog of PGF2α and has a potential antagonistic activity for the FP receptor.
-
cangrelor tetrasodiu...
Cangrelor tetrasodium is a reversible and selective antagonist of platelet P2Y12, with prompt and potent antiplatelet effects.cangrelor, a non-sepesific GPR17 antagonist, alleviates pulmonary fibrosis partly by inhibiting macrophage inflammation in mice.
